Success Metrics

Clinical Success Rate
38.9%

Based on 7 completed trials

Completion Rate
39%(7/18)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
11(61%)

Phase Distribution

Ph phase_3
14
78%
Ph phase_2
3
17%
Ph phase_1
1
6%

Phase Distribution

1

Early Stage

3

Mid Stage

14

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
3(16.7%)
Phase 3Large-scale testing
14(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

38.9%

7 of 18 finished

Non-Completion Rate

61.1%

11 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(7)
Terminated(11)

Detailed Status

Terminated11
Completed7

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
38.9%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (5.6%)
Phase 23 (16.7%)
Phase 314 (77.8%)

Trials by Status

completed739%
terminated1161%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04100473Phase 2

Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus

Completed
NCT03307512Phase 2

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Terminated
NCT00322257Phase 3

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Terminated
NCT00427154Phase 3

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

Terminated
NCT00411892Phase 3

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

Terminated
NCT00523042Phase 3

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Terminated
NCT00567775Phase 2

Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

Completed
NCT00725036Phase 3

Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

Completed
NCT00343980Phase 3

Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Terminated
NCT00472953Phase 3

Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

Terminated
NCT00331604Phase 3

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

Terminated
NCT00469586Phase 3

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

Terminated
NCT00348712Phase 3

Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Terminated
NCT00419718Phase 1

Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes

Completed
NCT00287066Phase 3

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Terminated
NCT00424437Phase 3

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

Completed
NCT00424333Phase 3

Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

Completed
NCT00370565Phase 3

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18